Cargando…

Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice

The aim of the present study was to confirm the effect of 2% rebamipide ophthalmic solution on a scopolamine-induced dry eye (DE) mouse model, and to investigate its effect on the ratio of T helper cell 17 (Th17)/regulatory T cell (Treg) numbers. C57BL/6 mice received subcutaneous injections of scop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Rongrong, Jiang, Yanhua, Zhou, Jing, Zhang, Jinsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472194/ https://www.ncbi.nlm.nih.gov/pubmed/30896815 http://dx.doi.org/10.3892/mmr.2019.10068

Ejemplares similares

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
por: Kashima, Tomoyuki, et al.
Publicado: (2014)

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
por: Ueda, Kaori, et al.
Publicado: (2015)

The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress
por: Simsek, Cem, et al.
Publicado: (2019)

Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients
por: Sakane, Yuri, et al.
Publicado: (2019)

Corrigendum to “Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients”
por: Sakane, Yuri, et al.
Publicado: (2020)

Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre
por: Jain, Kalpna, et al.
Publicado: (2023)

Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes
por: Shoji, Jun, et al.
Publicado: (2020)

Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye
por: Igarashi, Tsutomu, et al.
Publicado: (2018)

Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
por: Hayashi, Yusuke, et al.
Publicado: (2016)

The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials
por: Ballesteros-Sánchez, Antonio, et al.
Publicado: (2023)

The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
por: Eom, Youngsub, et al.
Publicado: (2023)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
por: Simsek, Cem, et al.
Publicado: (2019)

Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles
por: Nagai, Noriaki, et al.
Publicado: (2020)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
por: Fujimoto, Masahiro, et al.
Publicado: (2014)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

Centenarians Alleviate Inflammaging by Changing the Ratio and Secretory Phenotypes of T Helper 17 and Regulatory T Cells
por: Zhou, Lixing, et al.
Publicado: (2022)

Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
por: Sasaki, Hidenori, et al.
Publicado: (2014)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2019)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
por: Karpecki, Paul, et al.
Publicado: (2023)

Zinc Modulates the Priming of T Helper 1, T Helper 17, and T Regulatory Cells in Allogeneic and Autologous in vitro Models
por: Alrashidi, Hanan E, et al.
Publicado: (2022)

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells
por: Singh, Bhagirath, et al.
Publicado: (2013)

Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells
por: Calvo-Barreiro, Laura, et al.
Publicado: (2023)

T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients
por: Wang, Cheng, et al.
Publicado: (2021)

Effects of Rebamipide on Differences in Power and Axis of Corneal Astigmatism Between Two Intra-patient Keratometric Measurements in Dry Eyes
por: Teshigawara, Takeshi, et al.
Publicado: (2021)

Case Report: A Rare Orbital Abscess Caused by Dacryocystitis After Administration of Rebamipide Ophthalmic Suspension
por: Imamura, Hitoshi, et al.
Publicado: (2021)

The Functions of IL-23 and IL-2 on Driving Autoimmune Effector T-helper 17 Cells into the Memory Pool in Dry Eye Disease
por: Chen, Yihe, et al.
Publicado: (2020)

Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation
por: Pandiyan, Pushpa, et al.
Publicado: (2016)

A Study of the Changes of T Helper 17 Cells and Regulatory T Cells in Herpes Zoster
por: Kim, Min Sung, et al.
Publicado: (2017)

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives
por: Alunno, Alessia, et al.
Publicado: (2015)

Quantitative proteomic characterization and comparison of T helper 17 and induced regulatory T cells
por: Mohammad, Imran, et al.
Publicado: (2018)

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis
por: Iannello, Andrea, et al.
Publicado: (2019)

Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017)

Effectiveness of hyaluronic acid and arnica extract ophthalmic solution in reducing dry eye symptoms in pediatric population
por: Buzzonetti, Luca, et al.
Publicado: (2022)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

Impact of Perioperative Dry Eye Treatment with Rebamipide Versus Artificial Tears on Visual Outcomes After Cataract Surgery in Japanese Population
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
por: Nguyen, Theresa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e1jm6jmaoa70j4hasoh9husfse